Key achievements

Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. The values on which the Group was founded have always inspired growth for us and this is manifest in our achievements over the years.

Key achievements are listed below -

GSK leading the industry in first Access to Vaccines Index
The Access to Vaccines Index (ATVI) was published for the first time this week. Our longstanding commitments in vaccines to increasing innovation and access are recognised as leading the industry across all three areas: R&D; pricing and registration; and manufacturing and supply.

In R&D, GSK is highlighted for having the largest vaccine pipeline including projects that target all seven WHO priorities for vaccine R&D. Our tiered pricing strategy is recognised as being the most structured and transparent in the Pricing & Registration technical area; and under Manufacturing and Supply, GSK is acknowledged for having strategies to support access at a high level, strong internal supply-management processes and vaccine presentations that help overcome access barriers on the ground.

The 2017 ATVI Report is the first standalone vaccines analysis by the Access to Medicine Foundation, building on the Access to Medicine Index, which still includes vaccines in its scope. The report assesses how vaccine companies are improving access to high-priority vaccines for communities in need and provides a baseline of industry activity regarding access to vaccines, examining where and how companies are already taking action, highlighting good practices and opportunities for further action.

We are pleased to see GSK’s commitments in vaccines to increasing innovation and access are recognised as leading the industry in all three research areas. These efforts mean that more children in the world’s poorest countries are being immunised against deadly diseases.

The Access to Medicine Foundation will continue to present the ATVI findings to investors, governments and the public through a series of events over the coming months and GSK will continue to actively engage in these conversations.

For more information please see the website and full report.


A. Vaidheesh, Vice President, South Asia & Managing Director India, recognised as one of Asia's most promising leaders in 2016 by Economic Times
At the recently concluded, Asian Business Leaders conclave, held in Malaysia on 14th & 15th December, A. Vaidheesh was recognised as one of Asia's most promising leaders in 2016 by Economic Times. 


GSK India wins FICCI CSR Award for its newborn survival project
A. Vaidheesh, Managing Director & VP - South Asia and Ransom D’Souza, Head - Corporate Communications & CSR receive the prestigious award from Rajashree Birla (Director of Aditya Birla Group of Companies) and Narendra Singh Tomar (Minister of Rural Development, Panchayati Raj, Drinking Water and Sanitation).


Bombay Chamber Civic Awards
GSK won the Bombay Chamber Civic Awards in Social Development Category for its CSR initiatives. A. Vaidheesh, Managing Director & VP - South Asia while receiving the award commented, "Our CSR initiatives are a small step towards our global commitment for enhancing access to medicines and we are greatly encouraged by this recognition."


Association of Business Communicators of India (ABCI) award
GSK won the Association of Business Communicators of India (ABCI) award in 'Social Responsibility Communication' category for its media awareness campaign on Congenital Hypothyroidism. This important disease awareness campaign, spread across 12 cities, is the first step towards influencing policy changes for mandating newborn screening in India.


GSK ranked #1 in the world for doing well by doing good
Our ranking reflects the dedication and commitment of our people around the world to modernise the way we do business. We’ve changed how we incentivise our sales professionals, furthered our partnership with Save the Children, gained approval for the World’s first Malaria vaccine, opened up access to our Intellectual Property and committed to reinvesting 20% of our profits in Least Developed Countries. But the journey doesn’t end there. We haven’t achieved these things overnight and FORTUNE’s recognition will only inspire us to keep going.


GSK India recognised as a "Best Healthcare Brand" at The Economic Times Best Healthcare Brands 2016
GSK was recognised as a ‘Best Healthcare Brand’ by "The Economic Times Best Healthcare Brands 2016" in the pharmaceutical category: We were recognised as a ‘Best Healthcare Brand’ by "The Economic Times Best Healthcare Brands 2016" in the pharmaceutical category. This recognition was presented by J.P. Nadda, Union Minister of Health and Family Welfare and Jagdish Prasad, Director General of Health Services in New Delhi.


GSK ranked as the No. 1 Most Reputed Pharmaceutical brand amongst MNCs in India
GSK has ranked as the No.1 Most Reputed Pharmaceutical brand amongst MNC’s in India. The study was conducted by Bluebytes and TRA Research, across nine major Indian cities and GSK scored the highest in media perception among MNC pharma brands in the country.
The report is a study that highlights the Industry’s Reputation in terms of both Consumer and Media Perception. GSK had the highest Media Perception score among international pharmaceutical brands. Moreover, among the international brands, GSK scored the highest Respect Score, an important indicator of the awareness of the brand.
Mr. A. Vaidheesh, VP South Asia & Managing Director, India accepted the award presented by Mr. N. Chandramouli, CEO, TRA Research.


GSK wins The Economic Times Supply Chain award
GlaxoSmithKline Pharmaceuticals was felicitated at The Economic Times 3rd Annual Supply Chain Management Summit 2016 for exemplary supply chain management and logistics. The Economic Times awarded States and private companies, at the Summit at The Leela, Mumbai on June 24, 2016.
Raju Krishnaswamy, Regional Supply Chain Head, South Asia, GSK Pharmaceuticals, accepted the award on behalf of the company from Babul Supriyo, Honourable Union Minister of Urban Development, and for Housing and Urban Poverty Alleviation. Also felicitated at the event were the Transport Ministers of the States of Rajasthan and Karnataka. Among the private companies who won the award were Sanofi, Britannia, Colgate Palmolive, Marico and Parle Agro and Hindalco.
The Economic Times Editorial had earlier shortlisted various organisations that stand out from their contemporaries in Supply Chain practices and it is a proud moment that GSK has been recognised for its best-in-class supply chain practices.


Ranked 2nd in the pharmaceuticals sector in the ‘Most Respected Companies’ in India by Businessworld


Adjudged as one of India's Most Admired Companies by Fortune India


Gold award for Augmentin for ‘Marketing Excellence – Acute Therapy’ at the 2nd Annual AWACS Awards 


2nd prize for Nashik plant for its best practice on ‘ZAPs – Building culture of Zero Accident by engaging employees on safety initiatives’ at the Best Safety Practices Awards 2015